Cargando…
rAAV expressing recombinant neutralizing antibody for the botulinum neurotoxin type A prophylaxis
Botulinum neurotoxin (BoNT) is one of the most dangerous bacterial toxins and a potential biological weapon component. BoNT mechanism of pathological action is based on inhibiting the release of neurotransmitters from nerve endings. To date, anti-BoNT therapy is reduced to the use of horse hyperimmu...
Autores principales: | Derkaev, Artem A., Ryabova, Ekaterina I., Esmagambetov, Ilias B., Shcheblyakov, Dmitry V., Godakova, Svetlana A., Vinogradova, Irina D., Noskov, Anatoly N., Logunov, Denis Y., Naroditsky, Boris S., Gintsburg, Alexander L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9551282/ https://www.ncbi.nlm.nih.gov/pubmed/36238585 http://dx.doi.org/10.3389/fmicb.2022.960937 |
Ejemplares similares
-
Camelid VHHs Fused to Human Fc Fragments Provide Long Term Protection Against Botulinum Neurotoxin A in Mice
por: Godakova, Svetlana A., et al.
Publicado: (2019) -
rAAV expressing recombinant antibody for emergency prevention and long-term prophylaxis of COVID-19
por: Esmagambetov, Ilias B., et al.
Publicado: (2023) -
Single-domain antibody delivery using an mRNA platform protects against lethal doses of botulinum neurotoxin A
por: Panova, Eugenia A., et al.
Publicado: (2023) -
Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern
por: Favorskaya, Irina A., et al.
Publicado: (2022) -
Robust Long-term Transduction of Common Marmoset Neuromuscular Tissue With rAAV1 and rAAV9
por: Okada, Hironori, et al.
Publicado: (2013)